Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-15 to 2025-01-16
Current total value of award: $2605.38
Description: 4566939676!QUILLIVANT XR 25 MG/5 ML SUSP 120ML